2000- . 2020 , . , . , () 2020 2011 . 2012 2025 , , , .
, , . , , . ,
. , . .
. -20, . -20 - 1-2 .
2.3.
-20 - 2008-2014.
M&A | STADA | 24 - | |
M&A | 100% | ||
Sanofi-Aventis - | |||
Teva Ratiopharm | |||
Novartis AG Nestle 77% Alcon Inc; | |||
Merck Sharp & Dohme Schering-Plough | |||
Glaxo-SmithKline (ʓ | GSK . UCB Pharma. | ||
Novartis - | , , | ||
( ) Berlin-Chemie, Novo Nordisk Galenica | Berlin-Chemie, Novo Nordisk Galenica | ||
Nycomed, Teva | 50 . . | ||
M&A | Valeant Pharmaceuticals International 100% | ||
2.3. | |||
Bigpearl Trading Limited. | . .. | ||
M&A | Bever Pharmaceutical | ||
27 | |||
Valeant Pharmaceuticals Valeant | |||
M&A | ABBOTT | ̻ ( 36,6 | |
GLAXOSMITHKLINE NOVARTIS, | |||
NOVARTIS GLAXOSMITHKLINE |
: . .
|
|
, 2.3 , , , (M&A). 18 - 13 , 70 % . , 2020 . , .
, : - ; ; . , . ;
|
|